Los Altos, CA and Menlo Park, CA (November 14, 2014). Genome Compiler Corp., a Los Altos based synthetic biology software company entered into a collaborative agreement with DNA2.0, a leading provider of gene synthesis and bioengineering solutions located in Menlo Park, CA. Genome Compiler will be integrating DNA2.0’s gene synthesis services into their design platform, enabling users to design and directly order their DNA seamlessly. Users will benefit from built in tools regarding manufacturability, errors identification prior to placing their orders, order tracking and DNA2.0’s integrated vector repository.
“We are developing a comprehensive synthetic biology platform solution, that enables life scientist to imagine, design and create biological solutions to humanity’s challenges. Direct connection to DNA2.0 services will simplify the design to order user experience, giving a more streamlined approach to the programming of living things”, says Omri Drory, CEO of Genome Compiler. The solution will provide the industry with a comprehensive platform for all synthetic biology needs. Customers will benefit from direct connections to gene synthesis providers, automation facilities and an extensive suite of advanced bio-informatics tools and genetic repositories, all in one platform.
“DNA2.0 is delighted to be a partner with Genome Compiler as the premium gene synthesis provider. It further validates our market leadership position and our commitment to speed, quality, efficiency and outstanding customer services”, said Jeremy Minshull, PhD., cofounder and CEO of DNA2.0. DNA2.0’s gene synthesis process combines a highly automated molecular biology pipeline with sophisticated bioinformatics algorithms to provide collaborators and customers with a fully integrated program for bioengineering solutions.
About Genome Compiler
Based in Los Altos, CA and Tel-Aviv, Israel. Genome Compiler is a leader in computer aided design and collaboration platforms for the synthetic biology industry. Genome Compiler’s CAD tool allows scientists in the biotechnology, agriculture and pharmaceutical industries to design, debug and compile biological code, to develop better bio-based products faster.
DNA2.0 is the leading bioengineering solutions provider, offering an integrated pipeline of solutions, including gene design, optimization, synthesis, and platforms for protein and strain engineering. DNA2.0 explores novel applications for synthetic genes and the synergy between efficient gene design and protein optimization technologies. DNA2.0's tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline.